All Deliberate release (DR) articles

Journal

Evolution of GMO requirements for innovative investigational medicinal products upon transition to the EU CTR

2023-05-18T12:58:00Z

The EU CTR replaced the EU CTD on 31 January 2022, which impacts investigational medicinal products that fall under genetically modified organisms (GMO-IMPs).